triamcinolone acetonide 0.1% dental paste (Kenalog Orabase, Oralone) (cont.)

Medical Author:
Medical and Pharmacy Editor:

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

PREPARATIONS: 0.1% dental paste

STORAGE: Triamcinolone acetonide dental paste should be stored at controlled room temperature between 15 C and 25 C (59 F and 77 F).

DOSING: To treat oral lesions, use a small dab (about ¼ inch) to cover the lesion with a thin film. A larger quantity may be required for some lesions. For best results, only use enough paste to coat the lesion with a thin film. Do not rub in.

Depending on severity of symptoms, two or three applications per day may be required, preferably after meals. The paste should be applied at bedtime to allow contact with the lesion throughout the night. If symptoms do not improve in seven days, patients should seek further medical advice.

To prevent unwanted side effects, corticosteroids should be used for the shortest duration possible. Therapy should be discontinued as soon as control of symptoms is achieved.

Triamcinolone acetonide dental paste should not be used in the presence of fungal, viral, or bacterial infections of the mouth or throat.

DRUG INTERACTIONS: Since triamcinolone acetonide dental paste is used topically and for short durations, clinically significant blood absorption is not thought to occur. As a result, the risk for drug interactions with triamcinolone acetonide dental paste and other medications is relatively low.

PREGNANCY: Triamcinolone acetonide has been shown to cause birth defects in several animal species. As there are no adequate and well-controlled studies in pregnant women, the risk of birth defects in humans is not known. Triamcinolone acetonide dental paste should only be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Triamcinolone acetonide dental paste is classified as FDA pregnancy risk category C (Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks).

NURSING MOTHERS: It is not known if oral application of triamcinolone acetonide results in detectable secretions into breast milk. Therefore, to avoid unwanted adverse effects in the nursing infant, triamcinolone dental paste should be used cautiously in nursing mothers.

REFERENCE: FDA Prescribing Information.


Medically Reviewed by a Doctor on 6/11/2015


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index